Integrated molecular analysis of clear-cell renal cell carcinoma

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Genetics

• Publication date

  2013-06-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ng.2699PMID 23797736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data

  2013cited by this paper
• Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network

  2013cited by this paper
• Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.

  2013cited by this paper
• CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma.

  2013cited by this paper
• Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.

  2013cited by this paper
• Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy

  2013cited by this paper
• CUL 3 and NRF 2 Mutations Confer an NRF 2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma

  2013cited by this paper
• Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.

  2012cited by this paper
• TET2 promotes histone O-GlcNAcylation during gene transcription

  2012cited by this paper
• A crop of maize variants

  2012cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• BAP1 loss defines a new class of renal cell carcinoma

  2012cited by this paper
• Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

  2012cited by this paper
• Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

  2012cited by this paper
• Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma

  2012cited by this paper
• Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators

  2012cited by this paper
• Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect.

  2012cited by this paper
• Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma

  2011cited by this paper
• Frequent pathway mutations of splicing machinery in myelodysplasia

  2011cited by this paper
• PathScan: a tool for discerning mutational significance in groups of putative cancer genes

  2011cited by this paper
• Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type 2.

  2011cited by this paper
• Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma

  2011cited by this paper
• Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling

  2011cited by this paper
• Structural assembly of cullin-RING ubiquitin ligase complexes.

  2010cited by this paper
• Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

  2010cited by this paper
• Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns.

  2010cited by this paper
• EAU guidelines on renal cell carcinoma: 2014 update.

  2010cited by this paper
• Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• EAU guidelines on renal cell carcinoma: the 2010 update.

  2010cited by this paper
• Xp11 Translocation Renal Cell Carcinoma

  2010cited by this paper
• Mutation in TET2 in myeloid cancers.

  2009cited by this paper
• Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

  2009cited by this paper
• Renal cell carcinoma

  2009cited by this paper
• Human mutation rate associated with DNA replication timing

  2009cited by this paper
• Acquired mutations in TET2 are common in myelodysplastic syndromes

  2009cited by this paper
• Hepatocellular Carcinoma Associated with Hepatitis B Virus

  2009cited by this paper
• Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Patterns of somatic mutation in human cancer genomes

  2007cited by this paper
• Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays.

  2007cited by this paper
• Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap.

  2006cited by this paper
• Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer.

  2006cited by this paper
• Why do human diversity levels vary at a megabase scale?

  2005cited by this paper
• A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays.

  2005cited by this paper
• VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.

  2004cited by this paper
• BLAT--the BLAST-like alignment tool.

  2002cited by this paper
• VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma

  2002cited by this paper
• Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex.

  2000cited by this paper
• Plat-E: an efficient and stable system for transient packaging of retroviruses

  2000cited by this paper
• Tandem repeats finder: a program to analyze DNA sequences.

  1999cited by this paper
• Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.

  1999cited by this paper
• Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC

  1999cited by this paper
• Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma

  1997cited by this paper
• Identification of Elongin C Sequences Required for Interaction with the von Hippel-Lindau Tumor Suppressor Protein*

  1997cited by this paper
• Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II

  1995cited by this paper
• Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog.

  1995cited by this paper
• Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

  1994cited by this paper
• Mutations of the VHL tumour suppressor gene in renal carcinoma

  1994cited by this paper
• Renal cell carcinoma.

  1956cited by this paper
• BIOINFORMATICS ORIGINAL PAPER

  year unknowncited by this paper

• Multimodal-based analysis of single-cell ATAC-seq data enables highly accurate delineation of clinically relevant tumor cell subpopulations

  2026cites this paper
• Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinoma

  2026cites this paper
• PBRM1 Deficiency Reshapes an Immune Suppressive Microenvironment Through Epigenetic Tuning of PBRM1-KDM5C-IL6 Axis in ccRCC.

  2026cites this paper
• Insights into the mechanisms of drug resistance in renal cell carcinoma: from multi-omics perspective.

  2026cites this paper
• FKBP10 promotes M2 polarization of macrophage via MEK/ERK/CXCL8 axis and facilitates tumor progression in clear cell renal cell carcinoma

  2026cites this paper
• Belzutifan-induced tumor regression in sporadic hemangioblastoma: a case report and literature review

  2026cites this paper
• EPB41L family serves as a prognostic biomarker for kidney renal clear cell carcinoma

  2026cites this paper
• YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression

  2026cites this paper
• Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency).

  2026cites this paper
• Molecular and histopathological insights into renal neuroendocrine tumors (RenNETs): A comprehensive study.

  2026cites this paper
• The role of NSD1 gene expression in cancer pathogenesis: Opportunities for personalized therapeutics

  2026cites this paper
• Rhythms of risk: the intersection of clocks, cancer, and chronotherapy

  2026influential citation
• Hepatic Lenticular Degeneration With Renal Tumors: A Case Series

  2026cites this paper
• Convergent genomic and molecular features predict risk of metachronous metastasis in clear cell renal cell carcinoma.

  2026cites this paper
• Research Progress on the Interaction between Renal Cancer and the Tumor Microenvironment and Its Potential Therapeutic Strategies

  2026cites this paper
• ELOC-mutated Renal Cell Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Genetic Analysis of 35 Cases.

  2026cites this paper
• Molecular profiling of primary versus paired asynchronous metastatic clear cell renal cell carcinoma reveals heterogeneity in tumor immune microenvironment

  2026cites this paper
• Multi-channel multiphase CT-based deep learning and radiomics fusion model for noninvasive pathological grading of clear cell renal cell carcinoma

  2026cites this paper
• Identification of Predictive Genomic Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis of Real-World Clinicogenomic Data

  2026cites this paper
• NRF2: Master regulator of cellular homeostasis and therapeutic vulnerability in cancer

  2026cites this paper
• HIF1α Plays a Crucial Role in the Development of TFE3–Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid Synthesis

  2025cites this paper
• Machine learning identification of a novel vasculogenic mimicry-related signature and FOXM1’s role in promoting vasculogenic mimicry in clear cell renal cell carcinoma

  2025cites this paper
• Identification and Validation of a Prognostic Signature Based on mRNAs Associated with Low-Density Lipoprotein Receptor-Related Proteins for Kidney Renal Clear Cell Carcinoma: Insights Into Tumor Immune Microenvironment, Mutation Patterns, and Personalized Treatment Strategies

  2025cites this paper
• Constructing a PANoptosis-based prognostic signature to evaluate the immune landscape and therapeutic response in clear cell renal cell carcinoma

  2025cites this paper
• Expression pattern of cancer-associated cellular senescence genes in clear cell renal cell carcinoma distinguishes tumor subclasses with clinical implications

  2025cites this paper
• HIF-2α inhibitors in clear cell renal cell carcinoma: a clinical pharmacy perspective on lipid metabolism, therapeutic management, and resistance strategies

  2025cites this paper
• Identification and Validation of Cuproptosis-Related Signature to Predict Prognosis and Characterize Tumor Immune Infiltration in Kidney Clear Cell Carcinoma

  2025cites this paper
• Integrated RNA sequencing analysis and machine learning identifies a metabolism-related prognostic signature in clear cell renal cell carcinoma

  2025cites this paper
• LINC01913 and LINC01389 as the novel diagnostic tumor markers for the early-stage renal cell carcinoma.

  2025cites this paper
• Single-cell profiling of bone metastasis ecosystems reveals pivotal role of INSR+AEC in clear cell renal cell carcinoma

  2025cites this paper
• Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board

  2025cites this paper
• Multigenerational VHL family characterized by pathogenic germline ELOC variant: Response to belzutifan.

  2025cites this paper
• Dysregulation of the ubiquitin-proteasome system in von Hippel-Lindau syndrome: molecular insights and clinical perspectives

  2025cites this paper
• Molecular Profiling of Primary versus Paired Asynchronous Metastatic Clear Cell Renal Cell Carcinoma Reveals Heterogeneity in Tumor Immune Microenvironment

  2025cites this paper
• AI-driven multimodal algorithm predicts immunotherapy and targeted therapy outcomes in clear cell renal cell carcinoma

  2025cites this paper
• Developing and experimentally validating a glucocorticoid signaling-related gene signature to evaluate the prognosis and immunotherapeutic response in kidney renal clear cell carcinoma

  2025cites this paper
• Extrachromosomal circular miRNA-gene amplifications contribute to the renal cancer phenotype.

  2025cites this paper
• Adaptations of lipid metabolism in low-grade clear cell renal cell carcinoma are linked to cholesteryl ester accumulation

  2025cites this paper
• Anoikis-related genes predicts prognosis and therapeutic response in renal cell carcinoma

  2025cites this paper
• CLEC18A interacts with sulfated glycosaminoglycans and controls clear cell renal cell carcinoma progression

  2025cites this paper
• Construction and multi-omics analysis of ccRCC mitochondrial related gene machine learning model and validate of key gene FKBP10.

  2025cites this paper
• Single-cell sequencing technology in renal cancer: insights into tumor biology and clinical application

  2025cites this paper
• Prognostic significance of key immune cell functional alterations in clear cell renal cell carcinoma

  2025cites this paper
• Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinoma

  2025cites this paper
• A SWI/SNF complex-related genes signature predicts prognosis and immune infiltration in ccRCC with KCNK5 as a novel biomarker

  2025cites this paper
• PTGER4 Governs Immune Evasion and Therapy Resistance in Kidney Cancer via Ribosome Biogenesis Dysregulation

  2025cites this paper
• Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma

  2025cites this paper
• ELOC-mutated renal cell carcinoma: “Unexpected occurrence in a younger adult”

  2025cites this paper
• Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases

  2025cites this paper
• CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis

  2025cites this paper
• Sodium–Glucose Cotransporter 2 and Glucose Levels Affect Clear Cell Renal Cell Carcinoma Progression

  2025cites this paper
• Disclosing the development and focus of sequencing and omics studies in kidney neoplasm research

  2025cites this paper
• Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma

  2025cites this paper
• MtDNA copy number enrichment is associated with poor prognosis and eosinophilic morphology in clear cell renal cell carcinoma

  2025influential citation
• Translational Research Bridging Basic and Clinical Insights in Renal Cell Carcinoma: A Collaborative Review and Future Directions

  2025cites this paper
• Integrated multi-omics analysis identifies a machine learning-derived signature for predicting prognosis and therapeutic vulnerability in clear cell renal cell carcinoma.

  2025cites this paper
• ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor with Distinctive Genomic Characteristics.

  2025cites this paper
• Angiogenesis related gene signatures predict prognosis and guide therapeutic strategies in renal clear cell carcinoma

  2025cites this paper
• Determinants of late metastases in renal cell carcinoma.

  2025cites this paper
• KDM5C and KDM5D mutations have different consequences in clear cell renal cell carcinoma cells

  2025cites this paper
• Mefloquine Suppresses Metastasis in Renal Cell Carcinoma Through Targeting SPC25

  2025cites this paper
• Glycogen metabolism genes as a molecular signature for subtyping, prognostic prediction, and immunotherapy selection in clear cell renal cell carcinoma

  2025cites this paper
• Retinoid X receptor γ predicts the prognosis and is associated with immune infiltration in kidney renal clear cell carcinoma: a qRT-PCR, TCGA and in silico research

  2025cites this paper
• The CD70-CD27 axis in cancer immunotherapy: Predictive biomarker and therapeutic target.

  2025cites this paper
• The genomic landscape of metastatic clear-cell renal cell carcinoma and its prognostic value: a comprehensive analysis of a large real-world clinico-genomic database

  2025influential citation
• Pulmonary Metastasectomy in Renal Cell Carcinoma.

  2025cites this paper
• Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer

  2025cites this paper
• Molecular landscape of clear cell renal cell carcinoma: targeting the Wnt/β-catenin signaling pathway

  2025cites this paper
• Adverse reactions of four multi-targeted tyrosine kinase inhibitors: a descriptive analysis of the WHO-VigiAccess database

  2025cites this paper
• Liquid Biopsy as a New Tool for Diagnosis and Monitoring in Renal Cell Carcinoma

  2025cites this paper
• Metabolic reprogramming and immune microenvironment profiling in clear cell renal cell carcinoma: implications for prognosis, targeted therapy, and drug resistance

  2025cites this paper
• Integrative multi-omics reveal NSUN2 facilitates glycolysis and histone lactylation-driven immune evasion in renal carcinoma

  2025cites this paper
• Causal impact of genetically determined metabolites on kidney cancer and its subtypes: an integrated mendelian randomization and metabolomic study.

  2025cites this paper
• Characterisation of an autochthonous mouse ccRCC model of immune checkpoint inhibitor therapy resistance

  2025cites this paper
• Molecular Genetics of Renal Cell Carcinoma: A Narrative Review Focused on Clinical Relevance

  2025cites this paper
• Comprehensive Analysis of 15 Cases of ELOC-RCC and Identification of Novel Mutation Site.

  2025cites this paper
• Regulatory T cells and matrix-producing cancer associated fibroblasts contribute on the immune resistance and progression of prognosis related tumor subtypes in ccRCC

  2025cites this paper
• Systematically identification of survival-associated eQTLs in a Japanese kidney cancer cohort

  2025cites this paper
• Automatic segmentation of clear cell renal cell carcinoma based on deep learning and a preliminary exploration of the tumor microenvironment

  2025cites this paper
• A SETD2–CDK1–lamin axis maintains nuclear morphology and genome stability

  2025cites this paper
• Metabolic landscape of clear cell renal cell carcinoma and search for metabolites predictive of drug response

  2025cites this paper
• Renal surgery following HIF-2α antagonist therapy: Surgical indications, outcomes and growth kinetics.

  2025cites this paper
• Deubiquitinating Enzyme OTUDs: Focus on Cancers and Antiviral Response

  2025cites this paper
• pVHL regulates protein stability of the TCF/LEF transcription factor family via ubiquitin-independent proteasomal degradation

  2025cites this paper
• Current Status and Future Perspectives of Molecular Residual Disease Testing in Genitourinary Cancers

  2025cites this paper
• CD70-Targeted Radiotheranostics: Now and Future.

  2025cites this paper
• The evolution of renal cell carcinoma classification

  2025cites this paper
• ELOC-mutant renal cell carcinoma: practical diagnostic features and differential considerations

  2025cites this paper
• Distinct Tumor-Associated Macrophage Signatures Shape the Immune Microenvironment and Patient Prognosis in Renal Cell Carcinoma

  2025cites this paper
• Tuberous sclerosis complex-associated renal cell carcinoma, an underappreciated form of familial renal cancer, is characterized by activation of the TFEB/TFE3 pathway.

  2025cites this paper
• Explore the key genes and prognosis related to mitochondrial permeability transition driving necrosis gene in kidney renal clear cell carcinoma

  2025cites this paper
• Toxicological Impacts and Mechanistic Insights of Bisphenol a on Clear Cell Renal Cell Carcinoma Progression: A Network Toxicology, Machine Learning and Molecular Docking Study

  2025cites this paper
• ELOC(TCEB1)-mutated renal cell carcinoma: a case report and clinicopathological analysis

  2025cites this paper
• Development and validation of mitochondrial metabolism-related genes in the prognostic and immunological characterization of clear cell renal cell carcinoma

  2025cites this paper
• CTSS in the tumor microenvironment links immune escape and immunotherapy sensitivity in kidney renal clear cell carcinoma

  2025cites this paper
• Immune Landscape and Application of Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma

  2025cites this paper
• Disulfidptosis status influences prognosis and therapeutic response in clear cell renal cell carcinoma

  2024cites this paper
• HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma

  2024cites this paper
• VHL-dependence of EHHADH Expression in a Human Renal Cell Carcinoma Cell Line

  2024cites this paper
• Coiled‐coil domain containing 25 (CCDC25) regulates cell proliferation, migration, and invasion in clear cell renal cell carcinoma by targeting the ILK‐NF‐κB signaling pathway

  2024cites this paper